Since 1997, Peptron has developed platform technologies for
peptide-based medicines. In line with proprietary technologies, we are
developing sustained-release (SR) medications that extend the release profile
of the drug from weekly to monthly. Smart Depot™ brings the initial research
process to the final medication development and successful commercialization
phase with a high technological entrance barrier and excellent product
competitiveness, which enables us to expand our business and cooperate with global
pharmaceutical partners.
Smart Depot
technology: Sustained-release
(SR) technology without modification of API to extend the release profile and
...
